MedTrace Logo

Low Dose Doxycycline in the Treatment of Corneal Burn

NCT01886560 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-08-09

No results posted yet for this study

Summary

To evaluate the safety and efficacy of oral low dose doxycycline in the treatment of corneal burn.

Conditions

  • Eye Burns

Interventions

DRUG

Doxycycline

Tablets Doxycycline 50mg bid for 2 weeks,50mg qd for 10 weeks.

DRUG

Placebo

Tablets placebo one PO per day for 12 weeks

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Dan Liang, MD · Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01886560 on ClinicalTrials.gov